Literature DB >> 7023888

Pseudomembranous enterocolitis: a historical and clinical review.

T W O'Connor.   

Abstract

Pseudomembranous enterocolitis (PMEC) was first documented in 1893. Since this initial description, confusion has reigned in the medical literature concerning its nature and differentiation from such entities as necrotizing enterocolitis and staphylococcal enterocolitis. Since the 1950s, volumes have been written on PMEC and its association with a multitude of different antibiotics. PMEC has generally been used as somewhat of a "wastebasket" designation, being applied to any postoperative patient who develops significant diarrhea while on broad-spectrum antibiotics. More recently, a resurgence of interest in PMEC has led to its recognition as a specific disease entity and to a greater understanding of its etiology. The current review traces the history of PMEC, distinguishes if from similar disease processes, and describes its clinical presentation, diagnosis, and management. PMEC is particularly distinguished from antibiotic-associated diarrhea and certain forms of antibiotic-associated colitis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7023888     DOI: 10.1007/bf02626779

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  4 in total

1.  CT of pseudomembranous colitis.

Authors:  D Brunner; C Feifarek; D McNeely; P Haney
Journal:  Gastrointest Radiol       Date:  1984

2.  Predominant Staphylococcus aureus isolated from antibiotic-associated diarrhea is clinically relevant and produces enterotoxin A and the bicomponent toxin LukE-lukD.

Authors:  A Gravet; M Rondeau; C Harf-Monteil; F Grunenberger; H Monteil; J M Scheftel; G Prévost
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

Review 3.  The role of surgery in pseudomembranous enterocolitis.

Authors:  Y K Viswanath; C D Griffiths
Journal:  Postgrad Med J       Date:  1998-04       Impact factor: 2.401

4.  Neutropenic enterocolitis due to Clostridium septicum infection.

Authors:  A King; A Rampling; D G Wight; R E Warren
Journal:  J Clin Pathol       Date:  1984-03       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.